First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Stock Information for Envoy Med Inc Cl A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Envoy Med Inc Cl A

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
Envoy Medical Reports on First Quarter 2025 Results
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Envoy Medical to Participate in the 37th Annual ROTH Conference
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.